down arrow

Trident Lifeline

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0MKA01014
  • NSEID:
  • BSEID: 543616
INR
248.15
-12.85 (-4.92%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Net Sales
29.25
26.05
18.58
Other Operating Income
0.00
0.00
0.00
Total Operating income
29.25
26.05
18.58
Raw Material Cost
14.44
13.45
7.67
Purchase of Finished goods
1.25
6.74
2.72
(Increase) / Decrease In Stocks
0.01
-2.34
1.11
Employee Cost
2.33
1.43
0.97
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4.03
2.53
2.15
Total Expenditure (Excl Depreciation)
22.06
21.81
14.62
Operating Profit (PBDIT) excl Other Income
7.19
4.24
3.96
Other Income
1.04
1.37
0.71
Operating Profit (PBDIT)
8.23
5.61
4.67
Interest
0.99
0.40
0.20
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
7.24
5.21
4.47
Depreciation
0.70
0.68
0.29
Profit Before Tax
6.55
4.53
4.17
Tax
2.13
1.70
1.06
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.41
2.83
3.11
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.41
2.83
3.11
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.98
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5.39
2.83
3.11
Equity Capital
11.50
11.50
11.50
Face Value
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.69
2.46
2.7
Diluted Earnings per share
4.69
4.92
2.7
Operating Profit Margin (Excl OI)
24.58%
16.28%
21.31%
Gross Profit Margin
24.75%
20.0%
24.06%
PAT Margin
15.08%
10.86%
16.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 12.28% vs 40.20% in Mar 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 90.46% vs -9.00% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 69.58% vs 7.07% in Mar 2024

stock-summary

Interest

Growth in half year ended Sep 2024 is 147.50% vs 100.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Mar 2024

Compare Half Yearly Results Of Trident Lifeline With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
29.25
5,969.93
-5,940.68
-99.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
29.25
5,969.93
-5,940.68
-99.51%
Raw Material Cost
14.44
934.97
-920.53
-98.46%
Purchase of Finished goods
1.25
857.27
-856.02
-99.85%
(Increase) / Decrease In Stocks
0.01
-104.82
104.83
100.01%
Employee Cost
2.33
1,280.21
-1,277.88
-99.82%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4.03
1,470.50
-1,466.47
-99.73%
Total Expenditure (Excl Depreciation)
22.06
4,438.13
-4,416.07
-99.50%
Operating Profit (PBDIT) excl Other Income
7.19
1,531.80
-1,524.61
-99.53%
Other Income
1.04
210.03
-208.99
-99.50%
Operating Profit (PBDIT)
8.23
1,741.83
-1,733.60
-99.53%
Interest
0.99
18.01
-17.02
-94.50%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
7.24
1,723.82
-1,716.58
-99.58%
Depreciation
0.70
213.36
-212.66
-99.67%
Profit Before Tax
6.55
1,510.46
-1,503.91
-99.57%
Tax
2.13
314.99
-312.86
-99.32%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.41
1,195.47
-1,191.06
-99.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.41
1,195.47
-1,191.06
-99.63%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
0.98
-11.99
12.97
108.17%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5.39
1,189.96
-1,184.57
-99.55%
Equity Capital
11.50
40.06
-28.56
-71.29%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.69
29.70
-25.01
-84.21%
Diluted Earnings per share
4.69
29.65
-24.96
-84.18%
Operating Profit Margin (Excl OI)
24.58%
25.66%
0.00
-1.08%
Gross Profit Margin
24.75%
28.88%
0.00
-4.13%
PAT Margin
15.08%
20.13%
0.00
-5.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 29.25 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 12.28% vs 40.20% in Mar 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 5.39 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 90.46% vs -9.00% in Mar 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.19 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 69.58% vs 7.07% in Mar 2024

Half Yearly - Interest
Interest 0.99 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 147.50% vs 100.00% in Mar 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.58%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Mar 2024